The Purpose Of This Tender Procedure Is The Contracting Of The “Whole Genome Bisulfite Sequencing” (Wgbs) Service Using A “Low-Input Protocol” With A Minimum Depth Of 10X To Study Methylation Patterns And Then Bioinformatics Analysis In Charge Of The Project. Pi20/01697, Titled “Liquid Biopsy In Multiple Sclerosis. A Non-Invasive Approach To Determine The Prognosis Of The Disease And The Identification Of New Treatments”, Intended For The Clinical Neuroimmunology Group Of The Fundació Hospital Universitari Vall Hebron - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii ) And Co-Financed By The European Union.

Fundacio Hospital Universitari Vall d'Hebron - Institut de Recerca Spain has Released a tender for The Purpose Of This Tender Procedure Is The Contracting Of The “Whole Genome Bisulfite Sequencing” (Wgbs) Service Using A “Low-Input Protocol” With A Minimum Depth Of 10X To Study Methylation Patterns And Then Bioinformatics Analysis In Charge Of The Project. Pi20/01697, Titled “Liquid Biopsy In Multiple Sclerosis. A Non-Invasive Approach To Determine The Prognosis Of The Disease And The Identification Of New Treatments”, Intended For The Clinical Neuroimmunology Group Of The Fundació Hospital Universitari Vall Hebron - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii ) And Co-Financed By The European Union. in Consultancy. The tender was released on May 03, 2024.

Country - Spain

Summary - The Purpose Of This Tender Procedure Is The Contracting Of The “Whole Genome Bisulfite Sequencing” (Wgbs) Service Using A “Low-Input Protocol” With A Minimum Depth Of 10X To Study Methylation Patterns And Then Bioinformatics Analysis In Charge Of The Project. Pi20/01697, Titled “Liquid Biopsy In Multiple Sclerosis. A Non-Invasive Approach To Determine The Prognosis Of The Disease And The Identification Of New Treatments”, Intended For The Clinical Neuroimmunology Group Of The Fundació Hospital Universitari Vall Hebron - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii ) And Co-Financed By The European Union.

Deadline - login to view

GT reference number - 81430387

Product classification - Research and experimental development services